The SNARE Machinery in Mast Cell Secretion

The SNARE Machinery in Mast Cell Secretion

REVIEW ARTICLE published: 05 June 2012 doi: 10.3389/fimmu.2012.00143 The SNARE machinery in mast cell secretion Axel Lorentz 1*, Anja Baumann1, Joana Vitte 2,3 and Ulrich Blank 2,3* 1 Department of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany 2 INSERM UMRS 699, Paris, France 3 Laboratoire d’Excellence Inflamex, Faculté de Médicine, Site Xavier Bichat, Université Paris-Diderot, Paris, France Edited by: Mast cells are known as inflammatory cells which exert their functions in allergic and ana- Marc Benhamou, Institut National de phylactic reactions by secretion of numerous inflammatory mediators. During an allergic la Santé et de la Recherche Médicale, ε France response, the high-affinity IgE receptor, Fc RI, becomes cross-linked by receptor-bound IgE Reviewed by: and antigen resulting in immediate release of pre-synthesized mediators – stored in gran- Marc Benhamou, Institut National de ules – as well as in de novo synthesis of various mediators like cytokines and chemokines. la Santé et de la Recherche Médicale, Soluble N-ethylmaleimide-sensitive factor attachment protein (SNAP) receptors (SNARE) France proteins were found to play a central role in regulating membrane fusion events during Laura Eugenia Velazquez, Institut National de la Santé et de la exocytosis. In addition, several accessory regulators like Munc13, Munc18, Rab GTPases, Recherche Médicale/Université Paris secretory carrier membrane proteins, complexins, or synaptotagmins were found to be 13, France involved in membrane fusion. In this review we summarize our current knowledge about *Correspondence: the SNARE machinery and its mechanism of action in mast cell secretion. Axel Lorentz, Department of Nutritional Medicine, University of Keywords: mast cell, exocytosis, SNARE proteins Hohenheim, Fruwirthstraße 12, D-70593 Stuttgart, Germany. e-mail: axel.lorentz@ uni-hohenheim.de; Ulrich Blank, INSERM UMRS 699, Université Paris-Diderot, Faculté de Médecine Site Bichat, 16, rue Henri Huchard, F-75870 Paris CEDEX 18, France. e-mail: [email protected] INTRODUCTION mast cell specific proteases or through carrier vesicles emanating Mast cells are tissue-localized cells that upon activation release a from the Golgi including a large array of cytokines/chemokines whole variety of inflammatory mediators (Blank and Rivera, 2004; (Blank and Rivera, 2004; Sagi-Eisenberg, 2007). Considerable Rivera and Gilfillan, 2006). When released, their role is to pro- advances have been made in the understanding of the molecu- tect the body against infectious agents, injury or stress, however, lar machinery involved in vesicular secretion. In this review we inappropriate or chronic production may also have harmful con- provide an overview of the current knowledge on the mecha- sequences and engender inflammatory diseases (Bischoff, 2007; nisms of mast cell exocytosis as well as our current ideas about Kalesnikoff and Galli,2008;Abraham and St John,2010). Mast cells its mechanisms of regulation. are best-known for the role they play in allergic diseases after stim- ulation through IgE bound to high-affinity IgE receptors. However, CHARACTERISTICS OF MAST CELL EXOCYTOSIS recent years have made clear their general role both in protec- Transport of vesicles and exocytosis of mediators are cellular tive and disease-promoting inflammatory responses that involve processes that occur in all eukaryotic cells. Newly synthesized stimulation through a wide array of surface-expressed receptors mediators must be translocated into the endoplasmic reticulum including IgG Fc receptors, different types of G protein-coupled and then transported to the Golgi apparatus, where secretory car- receptors, Toll-like receptors, etc. (Bischoff, 2007; Kalesnikoff and goes are sorted into a variety of transport carriers for delivery to Galli, 2008; Abraham and St John, 2010; Beghdadi et al., 2011). their final destinations (Glick and Nakano, 2009). Some secretory While initial therapeutic strategies aiming to restrict mast cell cells including mast cells are capable of regulated exocytosis (Lacy activation largely focused on blocking the activation of the IgE and Stow, 2011). They store a wide range of factors and immune receptor and its early signaling events, targeting the late signaling mediators in pre-formed secretory granules (SG). Like in other steps has become a suitable alternative strategy. The latter approach hematopoietic cells with SG these are dual-function organelles would block the consequences of activation by many different containing lysosomal hydrolases such as β-hexosaminidase and receptor types converging into the same secretory pathways. cathepsin-D as found in all lysosomes as well as specific secre- With the exception of lipid-derived mediators that are synthe- tory inflammatory products (Stinchcombe and Griffiths, 2007). sized at the plasma membrane, mast cells secrete their mediators They are therefore often called secretory lysosomes to underline either by a process called degranulation from sources pre-stored in the close connection between endosomal/lysosomal and secretory cytoplasmic granules including for example histamine and certain compartments. Functionally, secretory lysosomes are unusual in www.frontiersin.org June 2012 | Volume 3 | Article 143 | 1 Lorentz et al. Mast cell secretory machinery that they serve both as a degradative and as a secretory compart- SNARE PROTEINS IN DEGRANULATION ment (Blott and Griffiths, 2002). Upon activation mast cells release The fusion between vesicles or the plasma membrane is not a a high amount of granule contents (Blank and Rivera,2004). Mem- spontaneous event. It requires a specific set of proteins called brane fusion, necessary for the stimulus-coupled release of granule Soluble N-ethylmaleimide-sensitive factor attachment protein recep- contents, requires that lipid molecules leave their bilayer orien- tors (SNAREs) that are highly conserved in all eukaryotes (Sudhof tation to merge two lipid bilayers (Cohen and Melikyan, 2004). and Rothman, 2009; Sudhof and Rizo, 2011). They were initially In neurons, where each vesicle interacts independently with the discovered by several independent approaches involving yeast plasma membrane, exocytosis is coupled to rapid endocytosis and genetics and biochemical purification procedures from synaptic regeneration of SG within milliseconds until seconds. In contrast, membranes and by the ability to bind soluble N-ethylmaleimide- mast cells are capable of releasing high amounts of their gran- sensitive factor (NSF)-attachment proteins, which are adapters ular content in response to a single stimulatory event, a process that connect the fusion machinery to the NSF ATPase (Novick called degranulation, and the regeneration of a granule can take et al., 1980; Bennett and Scheller, 1993; Sollner et al., 1993). The up to 72 h (Galli et al., 1984; Gandhi and Stevens, 2003; Blank SNARE machinery of membrane fusion involves different sets of and Rivera, 2004). A resting human intestinal mast cell and a proteins that lie on opposing membranes. They enable fusion by mast cell following activation induced degranulation are shown forming a highly stable tetrameric trans-SNARE complex through in Figure 1. Unlike neurons, mast cells SG can form channels four conserved 60–70 aa SNARE motifs (Sutton et al., 1998). Dis- by fusing with each other. This so-called compound exocytosis sociation of this complex is the energy-requiring step in fusion can either occur in a sequential or in a multivesicular manner. and is mediated by the NSF ATPase (Hanson et al., 1997). A typ- In sequential exocytosis, vesicles initially fuse with the plasma ical trans-SNARE complex at the plasma membrane includes a membrane followed by the fusion of underlying next vesicles vesicular SNARE (v-SNARE) such as vesicle associated membrane with the first vesicle. In multivesicular exocytosis, vesicles fuse protein (VAMP) that pairs with two target membrane SNAREs with each other before interacting with the plasma membrane (t-SNAREs) such as a Syntaxin (STX) molecule and synaptosome- (Alvarez de Toledo and Fernandez, 1990). Compound exocyto- associated protein of 23 (ubiquitous) or 25 (neuronal) kDa (SNAP- sis enables mast cells to discharge their contents very efficiently 23/25) containing two SNARE motifs (Sutton et al., 1998). To take (Pickett and Edwardson, 2006). In response to some stimuli, mast into account that v-SNAREs can also be found on the target mem- cells show also so-called piecemeal degranulation characterized by brane,for example in the case of homotypic vesicle fusion,SNAREs gradual loss of granule contents without detectable granule fusion. have also been classified structurally into R-SNAREs (correspond- Thus, piecemeal degranulation allows discharge of discrete pack- ing with few exceptions to v-SNAREs) based on a central R residue ets of granule-associated components without granule exocytosis in the 0 layer of the classical four-helix-bundle of the SNARE (Dvorak, 2005). While mast cell mediator release occurs typically, complex and Q-SNAREs with a central Q residue (Hong, 2005). although not exclusively, multi-directionally, other cell types of the Trans-SNARE complex, generally consists of either one v-SNARE immune system such as cytotoxic T cells or natural killer (NK) cells and two or three t-SNAREs or one R-SNARE and two or three Q- use secretory lysosomes to deliver proteins involved in their effec- SNAREs. Figure 2A illustrates SNARE complex formation catalyz- tor functions at the immune synapse in a uni-directional,polarized

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    18 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us